Editas Medicine, Inc. (NASDAQ:EDIT) Q4 2023 Earnings Call Transcript
Editas Medicine, Inc. beats earnings expectations. Reported EPS is $-0.23, expectations were $-0.52.
Stay updated with breaking news from Greg Harrison. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Editas Medicine, Inc. beats earnings expectations. Reported EPS is $-0.23, expectations were $-0.52.
Intellia Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.46, expectations were $-1.47. Intellia Therapeutics, Inc.
AUGUST 31, 1937 – FEBRUARY 19, 2024 Frances R. Smith, of Marshalltown, passed away on Monday, February 19, 2024 at The Willows of Marshalltown, with family a
Operator: Good day and welcome to the Travere Therapeutics Fourth Quarter and Full Year 2023 Financial Results and Corporate Update Conference Call. Today's conference is being recorded.
General Hospital (GH) spoilers update for Monday, January 29, reveals that Alexis Davis (Nancy Lee Grahn) will stop by the courtroom and find out